Serono Symposia International Foundation adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME) and all other professional organizations, as applicable, which state that programs awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the program (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so participants may form their own judgments, based on full disclosure of the facts. Further all opinions and recommendations presented during the program and all program-related materials neither imply an endorsement, nor a recommendation, on the part of Serono Symposia International Foundation. All presentations solely represent the independent views of the presenters/authors.
The following faculty provided information regarding significant commercial relationships and / or discussions of investigational or non EMEA/FDA approved (off-label) uses of drugs:
Claus Yding Andersen Declared no potential conflict of interest.
Maria do Carmo Borges de Souza Declared no potential conflict of interest.
Maria Bustillo Declared receipt of honoraria or consultation fees from Speaker's panel for EMD Serono. Declared to be a member of the Board of Directors of ARC Inc. Declared participation in a company sponsored speaker's bureau: EMD Serono
Luigi Devoto Declared no potential conflict of interest.
Sandro Esteves Declared receipt of consultation fees from Merckserono, Brazil.
Robert Fischer Declared receipt of honoraria or consultation fees from SSIE. Declared to be member of Scientific Committee SSIE.
José Franco Junior Declared no potential conflict of interest.
Antonio Gutiérrez Declared no potential conflict of interest.
Peter Humaidan Declared unrestricted research grant from Serono and Schering Plough
William Kearns Declared receipt of grants and contracts from Merck Serono. Declared receipt of honoraria or consultation fees from Merck Serono. Declared participation in a company sponsored speaker's bureau: Merck Serono
Mark Leondires Declared participation in a sponsored speaker's bureau: for Serono and Organon. Declared that during the conference, he will explain if his presentation includes discussion of any off-labeled or otherwise non-approved uses of any product.
Carlos Moreno Declared no potential conflict of interest.
Corinne Palatchi Declared no potential conflict of interest.
Paulo Serafini Declared no potential conflict of interest.
